tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Immutep and Dr. Reddy’s Forge Strategic Collaboration for Eftilagimod Alfa
PremiumCompany AnnouncementsImmutep and Dr. Reddy’s Forge Strategic Collaboration for Eftilagimod Alfa
1M ago
Midday Fly By: IBM to buy Confluent, Paramount goes hostile for Warner Bros.
Premium
The Fly
Midday Fly By: IBM to buy Confluent, Paramount goes hostile for Warner Bros.
1M ago
Immutep, Dr Reddy’s enters strategic collaboration for Eftilagimod Alfa
Premium
The Fly
Immutep, Dr Reddy’s enters strategic collaboration for Eftilagimod Alfa
1M ago
Immutep Secures A$4.6 Million R&D Incentive from French Government
PremiumCompany AnnouncementsImmutep Secures A$4.6 Million R&D Incentive from French Government
2M ago
Immutep receives EUR 2,588,954 R&D tax incentive from French Government
Premium
The Fly
Immutep receives EUR 2,588,954 R&D tax incentive from French Government
2M ago
Immutep Advances Key Clinical Trials and Strengthens Financial Position
Premium
Company Announcements
Immutep Advances Key Clinical Trials and Strengthens Financial Position
2M ago
Immutep announces Phase II study of eftilagimod alfa met primary endpoint
PremiumThe FlyImmutep announces Phase II study of eftilagimod alfa met primary endpoint
3M ago
Immutep Completes FDA Project Optimus, Advances Efti Trials
Premium
Company Announcements
Immutep Completes FDA Project Optimus, Advances Efti Trials
3M ago
Immutep announces completion of FDA Project Optimus requirements
Premium
The Fly
Immutep announces completion of FDA Project Optimus requirements
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100